Biopharma Stock Alert for La Jolla Pharmaceuticals Co. Issued by StockPreacher

Biopharma Stock Alert for La Jolla Pharmaceuticals Co. Issued by StockPreacher

DALLAS, March 5, 2010 (GLOBE NEWSWIRE) -- StockPreacher.com announces an
investment report featuring La Jolla Pharmaceuticals Co. (Pink Sheets:LJPC).
The report includes financial, comparative and investment analysis, and
industry information you need to know to make an educated investment decision.

The full report is available at: http://www.stockpreacher.com/n/LJPC

Get our alerts BEFORE the rest of the market. Follow us on Twitter:
http://twitter.com/StockPreacher

La Jolla Pharmaceutical Co. (LJPC) is a biopharmaceutical company focused on
the development and testing of Riquent® as a treatment for Lupus nephritis.
Lupus is an antibody-mediated disease caused by abnormal B cell production of
antibodies that attack healthy tissues. The Company's wholly owned subsidiary
is La Jolla Ltd.

Message Board Search for LJPC: http://www.boardcentral.com/boards/LJPC

In the report, the analyst notes:

"The Company has discontinued its clinical trials for Riquent and has
discontinued all research, development and clinical activities. In addition,
the Company has terminated substantially its entire workforce. Accordingly,
the Company's operating expenses and net loss for the three and nine months
ended September30, 2009, are expected to be substantially lower than reported
for the three and nine months ended September30, 2008.

"LJPC said this week its stock will be delisted from the Nasdaq on Thursday
March 4th, and added that shareholders did not respond to its plans to merge
with another drug company. The stock will be suspended from the Nasdaq
starting Thursday morning after a panel denied LJPC's request for an
extension. The Company does not have any products on the market, and trials of
the only drug it was developing, the lupus treatment Riquent, were suspended
more than a year ago. The Company proposed a merger with Adamis
Pharmaceuticals Corp., but it did not receive enough responses from
shareholders to hold a meeting."

To read the entire report visit: http://www.stockpreacher.com/n/LJPC

See what investors are saying about LJPC at penny stock forum

StockPreacher.com is a small-cap research and investment commentary provider.
StockPreacher.com strives to provide a balanced view of many promising
small-cap companies that would otherwise fall under the radar of the typical
Wall Street investor. We provide investors with an excellent first step in
their research and due diligence by providing daily trading ideas, and
consolidating the public information available on them. For more information
on StockPreacher, please visit: http://www.stockpreacher.com

StockPreacher.com Disclosure

StockPreacher.com is not a registered investment advisor and nothing contained
in any materials should be construed as a recommendation to buy or sell any
securities. StockPreacher.com is a Web site wholly owned by BlueWave Advisors,
LLC. StockPreacher.com nor its affiliates have a beneficial interest in the
mentioned company; nor have they received compensation of any kind for any of
the companies listed in this communication. Please read our report and visit
our Web site, StockPreacher.com, for complete risks and disclosures.

CONTACT:  StockPreacher.com
          Nic Lesmeister
          (469)-252-3505
          info@stockpreacher.com
 
Press spacebar to pause and continue. Press esc to stop.